Choate Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
744
-38
-5% -$14.1K 0.01% 403
2026
Q1
$229K Buy
782
+19
+2% +$6.25K ﹤0.01% 409
2025
Q4
$267K Buy
763
+37
+5% +$12.5K 0.01% 387
2025
Q3
$235K Sell
726
-52
-7% -$16.2K ﹤0.01% 380
2025
Q2
$303K Buy
778
+14
+2% +$5.63K 0.01% 341
2025
Q1
$332K Buy
764
+11
+1% +$4.42K 0.01% 314
2024
Q4
$278K Sell
753
-291
-28% -$122K 0.01% 343
2024
Q3
$543K Buy
1,044
+341
+49% +$182K 0.01% 257
2024
Q2
$381K Buy
703
+2
+0.3% +$1.06K 0.01% 280
2024
Q1
$363K Sell
701
-8
-1% -$3.98K 0.01% 306
2023
Q4
$334K Buy
709
+8
+1% +$3.7K 0.01% 294
2023
Q3
$305K Buy
+701
New +$318K 0.01% 292

Other funds holding ELV

Choate Investment Advisors's ELV Position: Q2 2026 in Review

Choate Investment Advisors reduced its Elevance Health (ELV) stake by 4.9% in Q2 2026, selling an estimated $14.1K and leaving 744 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #403.

Choate Investment Advisors first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. The position peaked at $543K in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Choate Investment Advisors held 744 shares of Elevance Health worth $288K as of Q2 2026.
  • Choate Investment Advisors sold 38 Elevance Health shares in Q2 2026, an estimated $14.1K.
  • Elevance Health made up 0.01% of Choate Investment Advisors's portfolio in Q2 2026, its #403 holding.
  • Choate Investment Advisors first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • Choate Investment Advisors's Elevance Health position peaked at $543K in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.